Response: Renal dosing of allopurinol results in suboptimal gout care by T Neogi et al
Ann Rheum Dis
.
2017 Jan;76(1):e2.
doi: 10.1136/annrheumdis-2016-210356.
Epub 2016 Nov 3.
Authors
Pascal Richette
1
2
,
Michael Doherty
3
,
Eliseo Pascual
4
,
Thomas Bardin
5
Affiliations
1
INSERM U1132 and University Paris-Diderot, Paris, France.
2
Department of Rheumatology, Hopital Lariboisiere, Paris, 75010, Île-de-France, France.
3
Academic Rheumatology, University of Nottingham, Nottingham, UK.
4
Department of Rheumatology, Hospital General Universitario de Alicante, Alicante, Spain.
5
Department of Rheumatology, Hôpital Lariboisière, Paris, France.
PMID:
27811145
DOI:
10.1136/annrheumdis-2016-210356
No abstract available
Keywords:
Gout; Patient perspective; Treatment.
Publication types
Letter
Comment
MeSH terms
Allopurinol*
Gout Suppressants
Gout*
Humans
Kidney
Uric Acid
Substances
Gout Suppressants
Uric Acid
Allopurinol